AMP Results Published in The New England Journal of Medicine

Mar 18, 2021
HIV virus neutralized by AMP
Graphic credit: HVTN


Researchers from the HIV Prevention Trials Network and HIV Vaccine Trials Network co-authored the New England Journal of Medicine article “Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.”

The two antibody-mediated prevention trials -- HVTN 704/HPTN 085 and HVTN 703/HPTN 081 -- are sponsored and funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.